Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis
Iyan Deposit Delivers Further Significant Graphite Intercepts from Surface in the Final Release of Assays
Tartisan Nickel Corp. Intersects 3.0 Metres of 2.17% Ni, 1.45% Cu at The Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario
